CleanSpark Inc vs Tilray Brands Inc — how do they compare? CleanSpark Inc trades at $12.13 (market cap $2.96B), while Tilray Brands Inc trades at $4.72 (market cap $649.42M). The key difference: CleanSpark Inc is far larger — about 4.6× Tilray Brands Inc's market cap, and CleanSpark Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| CLSK | TLRY | |
|---|---|---|
Market Cap | $2.96B | $649.42M |
Sector | Technology | Health |
52-Week High | $23.20 | $21.00 |
52-Week Low | $8.18 | $3.88 |
Enterprise Value | $3.95B | $816.55M |
Signals from Pluang's Aura AI — not financial advice
CleanSpark (CLSK) trades at $12.23, up 5.52% today but showing bearish technical signals with recent earnings misses. The company reported a Q3 2026 loss of $0.89 per share versus expectations of $0.47, continuing a trend of negative profitability despite securing a significant $6.6 billion AI data center lease. Revenue declined to $679 million in 2026 with a negative profit margin of -146.91%, though analyst consensus remains unanimously bullish with a $24.13 price target.
The stock presents a high-risk opportunity with strong institutional support but significant fundamental challenges. While the AI infrastructure pivot offers long-term potential, near-term execution risks and persistent losses require careful monitoring. The 100% buy rating from analysts suggests confidence in the strategic shift, but investors must weigh the substantial valuation premium against ongoing cash burn and competitive pressures.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Trailing returns across standard periods
Latest headlines on both assets
CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.
Read more on CLSK →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →